Personal tools

MCL coexpression mm9:185: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0005418!1.36e-08!5;UBERON:0002472!1.36e-08!5;UBERON:0008784!1.36e-08!5;UBERON:0006058!1.36e-08!5;UBERON:0004709!1.36e-08!5;UBERON:0002529!1.36e-08!5;UBERON:0010538!1.36e-08!5;UBERON:0005420!1.36e-08!5;UBERON:0010758!1.36e-08!5;UBERON:0000978!1.36e-08!5;UBERON:0002103!1.36e-08!5;UBERON:0000376!1.36e-08!5;UBERON:0000154!1.36e-08!5;UBERON:0010709!1.36e-08!5;UBERON:0005730!1.36e-08!5;UBERON:0003102!5.75e-08!22;UBERON:0000981!4.06e-07!4;UBERON:0003608!4.06e-07!4;UBERON:0003826!4.06e-07!4;UBERON:0008202!4.06e-07!4;UBERON:0004381!4.06e-07!4;UBERON:0007273!4.06e-07!4;UBERON:0010912!4.06e-07!4;UBERON:0002513!4.06e-07!4;UBERON:0004375!4.06e-07!4;UBERON:0010740!4.06e-07!4;UBERON:0010363!4.06e-07!4;UBERON:0003860!4.06e-07!4;UBERON:0002428!4.06e-07!4;UBERON:0010742!4.06e-07!4;UBERON:0002495!4.06e-07!4;UBERON:0003464!4.06e-07!4;UBERON:0003606!4.06e-07!4;UBERON:0005893!4.06e-07!4;UBERON:0009749!4.06e-07!4;UBERON:0010712!4.06e-07!4;UBERON:0010886!4.06e-07!4;UBERON:0005254!4.06e-07!4;UBERON:0010885!4.06e-07!4;UBERON:0010881!4.06e-07!4;UBERON:0010882!4.06e-07!4;UBERON:0007844!4.06e-07!4;UBERON:0001441!4.06e-07!4;UBERON:0011249!4.06e-07!4;UBERON:0002091!4.06e-07!4;UBERON:0003285!4.06e-07!4;UBERON:0004288!4.06e-07!4;UBERON:0010129!4.06e-07!4;UBERON:0006234!4.06e-07!4
|ontology_enrichment_uberon=UBERON:0005418!1.36e-08!5;UBERON:0002472!1.36e-08!5;UBERON:0008784!1.36e-08!5;UBERON:0006058!1.36e-08!5;UBERON:0004709!1.36e-08!5;UBERON:0002529!1.36e-08!5;UBERON:0010538!1.36e-08!5;UBERON:0005420!1.36e-08!5;UBERON:0010758!1.36e-08!5;UBERON:0000978!1.36e-08!5;UBERON:0002103!1.36e-08!5;UBERON:0000376!1.36e-08!5;UBERON:0000154!1.36e-08!5;UBERON:0010709!1.36e-08!5;UBERON:0005730!1.36e-08!5;UBERON:0003102!5.75e-08!22;UBERON:0000981!4.06e-07!4;UBERON:0003608!4.06e-07!4;UBERON:0003826!4.06e-07!4;UBERON:0008202!4.06e-07!4;UBERON:0004381!4.06e-07!4;UBERON:0007273!4.06e-07!4;UBERON:0010912!4.06e-07!4;UBERON:0002513!4.06e-07!4;UBERON:0004375!4.06e-07!4;UBERON:0010740!4.06e-07!4;UBERON:0010363!4.06e-07!4;UBERON:0003860!4.06e-07!4;UBERON:0002428!4.06e-07!4;UBERON:0010742!4.06e-07!4;UBERON:0002495!4.06e-07!4;UBERON:0003464!4.06e-07!4;UBERON:0003606!4.06e-07!4;UBERON:0005893!4.06e-07!4;UBERON:0009749!4.06e-07!4;UBERON:0010712!4.06e-07!4;UBERON:0010886!4.06e-07!4;UBERON:0005254!4.06e-07!4;UBERON:0010885!4.06e-07!4;UBERON:0010881!4.06e-07!4;UBERON:0010882!4.06e-07!4;UBERON:0007844!4.06e-07!4;UBERON:0001441!4.06e-07!4;UBERON:0011249!4.06e-07!4;UBERON:0002091!4.06e-07!4;UBERON:0003285!4.06e-07!4;UBERON:0004288!4.06e-07!4;UBERON:0010129!4.06e-07!4;UBERON:0006234!4.06e-07!4
|tfbs_overrepresentation_for_novel_motifs=0.334143,0.0871884,0.137785,1.02685,0.52997,0.744734,0.173178,0.470166,1.18449,0.0403289,0.316203,0.660907,0.471331,0.413246,0.599167,0,0.130791,0.498216,0.269603,0.329639,0.214842,0.839418,0.0489591,0.103734,0.296446,0.212178,0.149499,0.275182,0.0745272,0.0362049,0.476839,0.1884,0.316916,0.183653,0.126781,0.0417172,0.00139819,0.363725,0.763833,0.0412048,0.513765,0.0253014,0.446226,0.607701,0.0645202,0.0816978,0.307864,0.550712,0.3949,0.501724,0.773373,0.0681091,0.178629,0.282738,0.801132,0.191745,0.333884,0.15078,0.214042,0.189752,0.176282,0.0717217,0.265894,0.371468,0.447005,0.425113,0.399249,0.69938,0.515895,0.568332,0.11786,0.344557,0.0103093,0.319941,0.117094,0.163933,0.743423,0.29432,0.166165,0.222082,0.693764,0.140025,1.36413,0.023343,0.238089,0.00137754,0.0370099,0.125232,0.0944296,0.849071,0.455832,0.241442,0.571092,1.0575,0.125242,1.11543,0.199405,1.09082,0.0923623,0.00876344,1.48486,0.188228,0.74439,0.774712,0.385527,0.260958,0.909988,0.293493,0.230568,0.0351167,0.539933,0.271635,0.619418,0.0346541,0.461662,0.981771,0.00521933,0.228463,0.131473,0.0802677,0.32397,1.1584,1.23247,0.293252,0.507068,0.168323,0.716262,0.19211,0.398041,0.37326,0.717155,0.409907,0.374708,0.451727,0.479653,0.0323995,0.35185,0.263741,0.438962,1.20149,0.819322,0.403008,0.226608,0.194862,0.377074,0.107751,1.0734,1.16298,0.0694974,0.537121,0.310441,0.000611995,0.77517,0.0186722,0.449987,0.344269,0.518568,0.909492,0.836476,0.178118,1.13518,0.237514,0.503847,0.0584723,0.116665,0.196983,0.16634,0.0414659,1.06912
}}
}}

Revision as of 17:56, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr10:122608843..122608894,-p@chr10:122608843..122608894
-
Mm9::chr10:20611321..20611361,-p@chr10:20611321..20611361
-
Mm9::chr10:36348041..36348054,+p@chr10:36348041..36348054
+
Mm9::chr11:21270681..21270692,-p5@Ugp2
Mm9::chr11:66926940..66926976,-p@chr11:66926940..66926976
-
Mm9::chr11:67013593..67013609,+p1@Myh1
Mm9::chr11:67029448..67029459,-p@chr11:67029448..67029459
-
Mm9::chr11:87975881..87975888,+p16@Cuedc1
Mm9::chr13:83518057..83518059,-p@chr13:83518057..83518059
-
Mm9::chr13:83643136..83643158,+p7@Mef2c
Mm9::chr14:31693672..31693685,+p@chr14:31693672..31693685
+
Mm9::chr15:24236671..24236673,-p@chr15:24236671..24236673
-
Mm9::chr15:76993404..76993415,-p@chr15:76993404..76993415
-
Mm9::chr16:20678283..20678329,+p11@Eif4g1
Mm9::chr16:57352884..57352895,+p11@Filip1l
Mm9::chr17:7342812..7342832,+p@chr17:7342812..7342832
+
Mm9::chr18:60751417..60751432,-p2@Myoz3
Mm9::chr19:30699939..30699952,-p@chr19:30699939..30699952
-
Mm9::chr19:43602850..43602863,+p@chr19:43602850..43602863
+
Mm9::chr1:12982731..12982747,-p@chr1:12982731..12982747
-
Mm9::chr1:185863421..185863436,+p@chr1:185863421..185863436
+
Mm9::chr1:66992035..66992057,-p8@Myl1
Mm9::chr1:94009904..94009911,-p@chr1:94009904..94009911
-
Mm9::chr2:181314020..181314044,+p1@ENSMUST00000126672
Mm9::chr2:181314061..181314072,+p2@ENSMUST00000126672
Mm9::chr2:69507955..69507970,+p3@Kbtbd10
Mm9::chr3:122820113..122820116,-p@chr3:122820113..122820116
-
Mm9::chr3:69352872..69352898,+p4@Ppm1l
Mm9::chr4:124377615..124377628,+p3@Fhl3
Mm9::chr4:124377944..124377972,+p1@Fhl3
Mm9::chr4:128964917..128964929,+p5@Sync
Mm9::chr4:133712837..133712847,-p5@Ccdc21
Mm9::chr4:137591803..137591812,+p@chr4:137591803..137591812
+
Mm9::chr4:148688115..148688131,-p@chr4:148688115..148688131
-
Mm9::chr4:43528040..43528062,-p@chr4:43528040..43528062
-
Mm9::chr4:43536708..43536719,-p10@Tpm2
Mm9::chr4:57262011..57262022,-p@chr4:57262011..57262022
-
Mm9::chr4:73596402..73596419,-p@chr4:73596402..73596419
-
Mm9::chr4:73596683..73596694,-p3@2310002L09Rik
Mm9::chr4:73596718..73596737,-p2@2310002L09Rik
Mm9::chr4:73596738..73596757,-p1@2310002L09Rik
Mm9::chr6:108888660..108888701,-p@chr6:108888660..108888701
-
Mm9::chr6:128247107..128247125,-p@chr6:128247107..128247125
-
Mm9::chr7:109248409..109248420,-p4@Art5
Mm9::chr7:119885584..119885594,+p8@Tead1
Mm9::chr7:52693378..52693403,+p@chr7:52693378..52693403
+
Mm9::chr7:52699829..52699843,+p@chr7:52699829..52699843
+
Mm9::chr7:83374655..83374680,+p1@Agbl1
Mm9::chr7:83374741..83374752,+p2@Agbl1
Mm9::chr9:41793716..41793730,-p@chr9:41793716..41793730
-
Mm9::chr9:65112980..65112994,+p1@Cilp
Mm9::chr9:72541001..72541016,+p@chr9:72541001..72541016
+
Mm9::chr9:77195696..77195713,-p3@2310046A06Rik
Mm9::chrX:54032726..54032742,+p10@Fhl1


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

GO IDGO nameFDR corrected p-value
GO:0030017sarcomere9.36064978987318e-07
GO:0044449contractile fiber part9.36064978987318e-07
GO:0030016myofibril9.36064978987318e-07
GO:0043292contractile fiber9.36064978987318e-07
GO:0030018Z disc0.000219674389835757
GO:0031674I band0.000269104593422744
GO:0015629actin cytoskeleton0.00160500281119455
GO:0044430cytoskeletal part0.0055326680755427
GO:0007517muscle development0.0198485050763202
GO:0007507heart development0.0198485050763202
GO:0007275multicellular organismal development0.020504372274795
GO:0007010cytoskeleton organization and biogenesis0.0214133097494737
GO:0003983UTP:glucose-1-phosphate uridylyltransferase activity0.0214133097494737
GO:0051748UDP-sugar pyrophosphorylase activity0.0214133097494737
GO:0005856cytoskeleton0.0285012800517676
GO:0016459myosin complex0.0285012800517676
GO:0048513organ development0.0289571979001108
GO:0003779actin binding0.0299638512855307
GO:0004692cGMP-dependent protein kinase activity0.0299638512855307
GO:0004373glycogen (starch) synthase activity0.0299638512855307
GO:0003953NAD+ nucleosidase activity0.0398662947341668
GO:0005515protein binding0.0398662947341668
GO:0003012muscle system process0.0398662947341668
GO:0006936muscle contraction0.0398662947341668
GO:0004690cyclic nucleotide-dependent protein kinase activity0.0460527909081036
GO:0005862muscle thin filament tropomyosin0.0460527909081036
GO:0032502developmental process0.0486883141716843
GO:0008092cytoskeletal protein binding0.0486883141716843
GO:0048731system development0.0493006131586607



Relative expression of the co-expression cluster over median <br>Analyst:




Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>

Uber Anatomy
Ontology termp-valuen
hindlimb bud1.36e-085
stylopod1.36e-085
lower limb segment1.36e-085
multi-limb segment region1.36e-085
pelvic appendage1.36e-085
limb segment1.36e-085
paired limb/fin segment1.36e-085
pelvic appendage bud1.36e-085
subdivision of organism along appendicular axis1.36e-085
leg1.36e-085
hindlimb1.36e-085
hindlimb stylopod1.36e-085
posterior region of body1.36e-085
pelvic complex1.36e-085
hindlimb/pelvic fin field1.36e-085
surface structure5.75e-0822
femur4.06e-074
hindlimb long bone4.06e-074
upper leg bone4.06e-074
bone of hip region4.06e-074
skeleton of limb4.06e-074
pelvic appendage skeleton4.06e-074
subdivision of skeleton4.06e-074
endochondral bone4.06e-074
bone of free limb or fin4.06e-074
bone of appendage girdle complex4.06e-074
endochondral element4.06e-074
hindlimb mesenchyme4.06e-074
limb bone4.06e-074
bone of pelvic complex4.06e-074
long bone4.06e-074
hindlimb bone4.06e-074
limb long bone4.06e-074
leg bone4.06e-074
limb mesenchyme4.06e-074
limb skeleton subdivision4.06e-074
hindlimb bone pre-cartilage condensation4.06e-074
upper leg mesenchyme4.06e-074
hindlimb cartilage element4.06e-074
limb cartilage element4.06e-074
limb bone pre-cartilage condensation4.06e-074
cartilage element4.06e-074
hindlimb skeleton4.06e-074
appendicular skeletal system4.06e-074
appendicular skeleton4.06e-074
limb of embryo4.06e-074
skeleton4.06e-074
femur cartilage element4.06e-074
femur pre-cartilage condensation4.06e-074


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=MCL_coexpression_mm9:185&oldid=2561405"